Mandate

Vinge advises Bridgepoint Growth in conjunction with the entry of a partnership in DCHud Holding AB

Diagnostiskt Centrum Hud, the leading provider of medical dermatology services in Sweden, partnered with Bridgepoint Growth to further support the company’s expansion.

Today DCH operates six clinics across four Swedish cities and is the clear market leader in Sweden.

Vinge’s team primarily consisted of partner Daniel Rosvall together with associates Michaela Cronemyr, Elsie Nassar, Ellinor Wargenbrant and Olivia Belding (M&A) and Sara Strandberg (employment), Lisa Hörnqvist (commercial agreements) and Tove Lövgren Frisk (corporate, crime & compliance).

Related

Vinge advises Pricer in connection with Vusion’s public takeover offer

On 17 November 2026, VusionGroup S.A., a French public limited company listed on Euronext Paris, announced a recommended public takeover offer to the shareholders of Pricer Aktiebolag (publ) to acquire all shares in Pricer for a consideration of SEK 6.00 per share. The offer values all shares in Pricer at approximately SEK 980.4 million.
November 20, 2026

Vinge has advised Rite Ventures in connection with sale of shares in Qliro AB (publ)

Vinge has advised Rite Ventures in connection with the sale of shares in Qliro AB (publ) to Svea Bank AB (publ).
November 19, 2026

Vinge advises Röko AB (publ) in connection with the establishment of its MTN programme

Vinge has advised Röko AB (publ) ("Röko") on the establishment of a medium-term note programme (the "MTN Programme") with a framework amount of SEK 5 billion.
November 13, 2026